Totals
- Total revenue
- $628,809,066
- Total expenses
- $628,809,066
- Contributions and grants received
- $628,809,066
- Grants paid
- $628,809,066
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
- Total assets, end of year
- $0
- Total liabilities, end of year
- $0
- Net assets or fund balances, end of year
- $0
- Program services expenses (Part IX)
- $628,809,066
- Management and general expenses
- $0
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $628,809,066
Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$0
-
1b · Membership dues
$0
-
1c · Fundraising events
$0
-
1d · Related organizations
$0
-
1e · Government grants (contributions)
$0
-
1f · All other contributions, gifts and grants
$628,809,066
-
1g · Noncash contributions included above
$628,809,066
-
6c · Rental income or loss
real property $0 · personal property $0
-
7c · Gain or loss
securities $0 · other assets $0
-
8a · Fundraising events: contributions included on line 1c
$0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $0 · program services $0
-
2 · Grants to domestic individuals
total $0 · program services $0
-
3 · Grants to foreign organizations and individuals
total $628,809,066 · program services $628,809,066
-
4 · Benefits paid to or for members
total $0 · program services $0
-
5 · Compensation of officers, directors and key employees
total $0 · program services $0 · management and general $0 · fundraising $0
-
6 · Compensation of disqualified persons
total $0 · program services $0 · management and general $0 · fundraising $0
-
7 · Other salaries and wages
total $0 · program services $0 · management and general $0 · fundraising $0
-
8 · Pension plan contributions
total $0 · program services $0 · management and general $0 · fundraising $0
-
9 · Other employee benefits
total $0 · program services $0 · management and general $0 · fundraising $0
-
10 · Payroll taxes
total $0 · program services $0 · management and general $0 · fundraising $0
-
11a · Fees: management
total $0 · program services $0 · management and general $0 · fundraising $0
-
11b · Fees: legal
total $0 · program services $0 · management and general $0 · fundraising $0
-
11c · Fees: accounting
total $0 · program services $0 · management and general $0 · fundraising $0
-
11d · Fees: lobbying
total $0 · program services $0 · management and general $0 · fundraising $0
-
11e · Fees: professional fundraising services
total $0 · fundraising $0
-
11f · Fees: investment management
total $0 · program services $0 · management and general $0 · fundraising $0
-
11g · Fees: other
total $0 · program services $0 · management and general $0 · fundraising $0
-
12 · Advertising and promotion
total $0 · program services $0 · management and general $0 · fundraising $0
-
13 · Office expenses
total $0 · program services $0 · management and general $0 · fundraising $0
-
14 · Information technology
total $0 · program services $0 · management and general $0 · fundraising $0
-
15 · Royalties
total $0 · program services $0 · management and general $0 · fundraising $0
-
16 · Occupancy
total $0 · program services $0 · management and general $0 · fundraising $0
-
17 · Travel
total $0 · program services $0 · management and general $0 · fundraising $0
-
18 · Travel or entertainment for public officials
total $0 · program services $0 · management and general $0 · fundraising $0
-
19 · Conferences, conventions and meetings
total $0 · program services $0 · management and general $0 · fundraising $0
-
20 · Interest
total $0 · program services $0 · management and general $0 · fundraising $0
-
21 · Payments to affiliates
total $0 · program services $0 · management and general $0 · fundraising $0
-
22 · Depreciation, depletion and amortization
total $0 · program services $0 · management and general $0 · fundraising $0
-
23 · Insurance
total $0 · program services $0 · management and general $0 · fundraising $0
-
24e · All other expenses
total $0 · program services $0 · management and general $0 · fundraising $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $0 · end of year $0
-
2 · Savings and temporary cash investments
beginning of year $0 · end of year $0
-
3 · Pledges and grants receivable
beginning of year $0 · end of year $0
-
4 · Accounts receivable
beginning of year $0 · end of year $0
-
5 · Loans and receivables from officers and key people
beginning of year $0 · end of year $0
-
6 · Loans and receivables from disqualified persons
beginning of year $0 · end of year $0
-
7 · Other notes and loans receivable
beginning of year $0 · end of year $0
-
8 · Inventories for sale or use
beginning of year $0 · end of year $0
-
9 · Prepaid expenses and deferred charges
beginning of year $0 · end of year $0
-
10c · Land, buildings and equipment, net
beginning of year $0
-
11 · Investments: publicly traded securities
beginning of year $0 · end of year $0
-
12 · Investments: other securities
beginning of year $0 · end of year $0
-
13 · Investments: program-related
beginning of year $0 · end of year $0
-
14 · Intangible assets
beginning of year $0 · end of year $0
-
15 · Other assets
beginning of year $0 · end of year $0
-
17 · Accounts payable and accrued expenses
beginning of year $0 · end of year $0
-
18 · Grants payable
beginning of year $0 · end of year $0
-
19 · Deferred revenue
beginning of year $0 · end of year $0
-
20 · Tax-exempt bond liabilities
beginning of year $0 · end of year $0
-
21 · Escrow or custodial account liability
beginning of year $0 · end of year $0
-
22 · Loans and payables to officers and key people
beginning of year $0 · end of year $0
-
23 · Secured mortgages and notes payable
beginning of year $0 · end of year $0
-
24 · Unsecured notes and loans payable
beginning of year $0 · end of year $0
-
25 · Other liabilities
beginning of year $0 · end of year $0
-
27 · Net assets without donor restrictions
beginning of year $0 · end of year $0
-
28 · Net assets with donor restrictions
beginning of year $0 · end of year $0
Mission and programs · 2022
Mission
As a supporting organization, support the global health efforts of The Task Force for Global Health, Inc. by principally receiving donated phamaceuticals and coordinating the shipment to designated countries for the treatment of blinding trachoma, river blindness and vaccine preventable diseases.
Activities or mission (Part I)
As a supporting organization, provide support to the global health initiatives of The Task Force for Global Health,Inc.
-
In 2023, over 376 million treatments were approved for river blindness and LF elimination-a modest increase from 2022 when 364 million treatments were approved. This includes nearly 58 million treatments approved for the implementation of "triple therapy" in 12 countries. So far, Merck has shipped Mectizan to 22 countries and territories to facilitate the implementation of IDA to accelerate the elimination of LF in countries where river blindness is not endemic. As of the end of 2023, cumulatively, more than 5.5 billion Mectizan treatments have been approved by the Mectizan Donation Program, and more than 13 billion tablets have been shipped to 58 endemic countries by Merck since the donation was announced in 1987. In 2023, progress was reported for both diseases. For river blindness, 47 million no longer need treatment in 13 countries; for LF, over 305 million no longer need treatment in 20 countries. The Mectizan Donation Program and its partners are on track to meet the elimination targets established by the World Health Organization's 2021-2030 Neglected Tropical Disease Road Map to eliminate onchocerciasis in 12 countries and lymphatic filariasis in 58 countries.
Expenses $56,375,444 · Revenue $56,375,444
-
The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma, even in the midst of a global pandemic. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of Zithromax(R) to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2022 and August 2023, ITI organized just-in-time shipments of 41.5 million treatments for trachoma to be distributed at MDAs in 15 countries. As of August 2023, ITI has shipped more than 1.022 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 3,700 surveys across 52 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.2 billion people in 2000 to 115.7 million in April 2023 according to the World Health Organization's (WHO) Weekly Epidemiological Record (WER). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality.
Expenses $572,433,622 · Revenue $572,433,622
As filed on the 2022 return.
Listed in Part VII
-
David A Ross
Chairman
- Total calculated
- $417,725
- From this org
- $0
- From related orgs
- $0
- Other
- $417,725
- Hours/week
- 1 + 39 related
Schedule J breakdown matched by us
- Base
- $0 + $380,847 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $23,444 related
- Nontaxable benefits
- $0 + $13,434 related
- Filer's total
- $0 + $417,725 related
-
Patrick O'Carroll
Chairman
- Total calculated
- $357,404
- From this org
- $0
- From related orgs
- $0
- Other
- $357,404
- Hours/week
- 1 + 39 related
Schedule J breakdown matched by us
- Base
- $0 + $328,667 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $27,450 related
- Nontaxable benefits
- $0 + $1,287 related
- Filer's total
- $0 + $357,404 related
-
Mark McKinlay
Officer
- Total calculated
- $341,085
- From this org
- $0
- From related orgs
- $0
- Other
- $341,085
- Hours/week
- 1 + 39 related
Schedule J breakdown matched by us
- Base
- $0 + $301,101 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $25,207 related
- Nontaxable benefits
- $0 + $14,777 related
- Filer's total
- $0 + $341,085 related
-
William P Nichols
Treasurer
- Total calculated
- $322,266
- From this org
- $0
- From related orgs
- $0
- Other
- $322,266
- Hours/week
- 1 + 39 related
Schedule J breakdown matched by us
- Base
- $0 + $295,269 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $25,833 related
- Nontaxable benefits
- $0 + $1,164 related
- Filer's total
- $0 + $322,266 related
-
Ellen Wild
Officer
- Total calculated
- $206,634
- From this org
- $0
- From related orgs
- $0
- Other
- $206,634
- Hours/week
- 1 + 39 related
Schedule J breakdown matched by us
- Base
- $0 + $188,520 related
- Bonus
- $0
- Other
- $0
- Deferred
- $0 + $17,073 related
- Nontaxable benefits
- $0 + $1,041 related
- Filer's total
- $0 + $206,634 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
None.
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Schedule J, Part I, Line 3
- The organization does not have employees but has officers who are paid by the related organization
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
No itemized grants to organizations on this return.
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 0
- Expenditures and investments (line 3c)
- $628,809,066
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| Central America and the Caribbean | 0 | 0 | Program Services | Donated mectizan drugs for treatment | $41,160 |
| East Asia and the Pacific | 0 | 0 | Program Services | Donated mectizan and zithromax drugs for treatments | $2,514,393 |
| Middle East and North Africa | 0 | 0 | Program Services | Donated mectizan and zithromax drugs for treatments | $17,130,024 |
| South Asia | 0 | 0 | Program Services | Donated mectizan drugs for treatments | $34,592,880 |
| Sub-Saharan Africa | 0 | 0 | Program Services | Donated mectizan and zithromax drugs for treatments | $574,530,609 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| Central America and the Caribbean | $0 | N/A | $41,160 | Donated mectizan drugs | Lower of donor's or market value |
| East Asia and the Pacific | $0 | N/A | $2,514,394 | Donated mectizan and zithromax drugs | Lower of donor's or market value |
| Middle East and North Africa | $0 | N/A | $17,130,025 | Donated mectizan and zithromax drugs | Lower of donor's or market value |
| South Asia | $0 | N/A | $34,592,880 | Donated mectizan and zithromax drugs | Lower of donor's or market value |
| Sub-Saharan Africa | $0 | N/A | $574,530,609 | Donated mectizan and zithromax drugs | Lower of donor's or market value |
- Grantees recognized as charities or with a 501(c)(3) equivalency letter (Part II line 2)
- 34
- Other grantees (Part II line 3)
- 0
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- Yes
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
The Task Force for Global Health Inc
501(c)(3) · Management and distribution of donated medicines · GA
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 28 February 2024
- IRS schema version
- 2022v5.0
- Source object
- 202441809349300544
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.